Overview

Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects

Status:
Completed
Trial end date:
2014-01-06
Target enrollment:
0
Participant gender:
All
Summary
A Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 and Midazolam in Healthy Adult Subjects
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Shire
Treatments:
Midazolam
Criteria
Inclusion Criteria:

- Normal healthy male and female volunteers between the ages of 18 and 65, inclusive

- Serum ferritin, hemoglobin and erythrocyte indices within normal range

Exclusion Criteria:

- Evidence of any active or chronic disease